Skip to main content
OpenTrials

Clinical trial condition

Neuronal Ceroid-Lipofuscinoses

Explore clinical trials studying Neuronal Ceroid-Lipofuscinoses. Study availability and eligibility vary by location and protocol.

42 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Neuronal Ceroid-Lipofuscinoses trial results

Completed

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

NCT01907087

Conditions
Batten Disease, CLN2 Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • University Hamburg-Eppendorf Hamburg, Germany
  • Bambino Gesù Children's Hospital Rome, Italy
  • Guy's & St. Thomas NHS Foundation Trust London, United Kingdom
View Trial Details
Completed

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

NCT00531037

Conditions
Arrhythmias, Cardiac, Atrioventricular Block, Cardiac Conduction System Disease, +18 more
Locations
  • Baptist Princeton Birmingham Birmingham, Alabama, United States
  • Tennessee Valley Sheffield Sheffield, Alabama, United States
  • Cardiovascular Assoc. Of Mesa Mesa, Arizona, United States
  • O'Connor Hospital San Jose San Jose, California, United States
View all 129 locations
View Trial Details

Related conditions